207 related articles for article (PubMed ID: 35743289)
21. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
[TBL] [Abstract][Full Text] [Related]
22. The Golgi-resident protein ACBD3 concentrates STING at ER-Golgi contact sites to drive export from the ER.
Motani K; Saito-Tarashima N; Nishino K; Yamauchi S; Minakawa N; Kosako H
Cell Rep; 2022 Dec; 41(12):111868. PubMed ID: 36543137
[TBL] [Abstract][Full Text] [Related]
23. The structural basis for the sensing and binding of cyclic di-GMP by STING.
Huang YH; Liu XY; Du XX; Jiang ZF; Su XD
Nat Struct Mol Biol; 2012 Jun; 19(7):728-30. PubMed ID: 22728659
[TBL] [Abstract][Full Text] [Related]
24. Unraveling the Binding Mode of Cyclic Adenosine-Inosine Monophosphate (cAIMP) to STING through Molecular Dynamics Simulations.
Wang M; Fan B; Lu W; Ryde U; Chang Y; Han D; Lu J; Liu T; Gao Q; Chen C; Xu Y
Molecules; 2024 Jun; 29(11):. PubMed ID: 38893524
[TBL] [Abstract][Full Text] [Related]
25. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.
Shae D; Becker KW; Christov P; Yun DS; Lytton-Jean AKR; Sevimli S; Ascano M; Kelley M; Johnson DB; Balko JM; Wilson JT
Nat Nanotechnol; 2019 Mar; 14(3):269-278. PubMed ID: 30664751
[TBL] [Abstract][Full Text] [Related]
26. Selective Loss of Responsiveness to Exogenous but Not Endogenous Cyclic-Dinucleotides in Mice Expressing STING-R231H.
Walker MM; Kim S; Crisler WJ; Nguyen K; Lenz LL; Cambier JC; Getahun A
Front Immunol; 2020; 11():238. PubMed ID: 32153571
[TBL] [Abstract][Full Text] [Related]
27. Activation of STING by targeting a pocket in the transmembrane domain.
Lu D; Shang G; Li J; Lu Y; Bai XC; Zhang X
Nature; 2022 Apr; 604(7906):557-562. PubMed ID: 35388221
[TBL] [Abstract][Full Text] [Related]
28. Cyclic di-GMP sensing via the innate immune signaling protein STING.
Yin Q; Tian Y; Kabaleeswaran V; Jiang X; Tu D; Eck MJ; Chen ZJ; Wu H
Mol Cell; 2012 Jun; 46(6):735-45. PubMed ID: 22705373
[TBL] [Abstract][Full Text] [Related]
29. Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP.
Shang G; Zhang C; Chen ZJ; Bai XC; Zhang X
Nature; 2019 Mar; 567(7748):389-393. PubMed ID: 30842659
[TBL] [Abstract][Full Text] [Related]
30. STING inhibitors target the cyclic dinucleotide binding pocket.
Hong Z; Mei J; Li C; Bai G; Maimaiti M; Hu H; Yu W; Sun L; Zhang L; Cheng D; Liao Y; Li S; You Y; Sun H; Huang J; Liu X; Lieberman J; Wang C
Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34099558
[TBL] [Abstract][Full Text] [Related]
31. The Many Ways to Deal with STING.
Coderch C; Arranz-Herrero J; Nistal-Villan E; de Pascual-Teresa B; Rius-Rocabert S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240378
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of Original Cyclic Dinucleotide Analogues Using the Sulfo-click Reaction.
Amador R; Vasseur JJ; Birkuš G; Bignon E; Monari A; Clavé G; Smietana M
Org Lett; 2024 Feb; 26(4):819-823. PubMed ID: 38236576
[TBL] [Abstract][Full Text] [Related]
33. STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection.
Barker JR; Koestler BJ; Carpenter VK; Burdette DL; Waters CM; Vance RE; Valdivia RH
mBio; 2013 Apr; 4(3):e00018-13. PubMed ID: 23631912
[TBL] [Abstract][Full Text] [Related]
34. Structural Flexibility and Conformation Features of Cyclic Dinucleotides in Aqueous Solutions.
Che X; Zhang J; Zhu Y; Yang L; Quan H; Gao YQ
J Phys Chem B; 2016 Mar; 120(10):2670-80. PubMed ID: 26878265
[TBL] [Abstract][Full Text] [Related]
35. Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma.
Nakamura T; Miyabe H; Hyodo M; Sato Y; Hayakawa Y; Harashima H
J Control Release; 2015 Oct; 216():149-57. PubMed ID: 26282097
[TBL] [Abstract][Full Text] [Related]
36. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
[TBL] [Abstract][Full Text] [Related]
37. Supramolecular Cyclic Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy.
Xu L; Deng H; Wu L; Wang D; Shi L; Qian Q; Huang X; Zhu L; Gao X; Yang J; Su Y; Feng J; Zhu X
ACS Nano; 2023 Jun; 17(11):10090-10103. PubMed ID: 37253192
[TBL] [Abstract][Full Text] [Related]
38. Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP.
Shang G; Zhu D; Li N; Zhang J; Zhu C; Lu D; Liu C; Yu Q; Zhao Y; Xu S; Gu L
Nat Struct Mol Biol; 2012 Jun; 19(7):725-7. PubMed ID: 22728660
[TBL] [Abstract][Full Text] [Related]
39. Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential.
Dejmek M; Šála M; Brazdova A; Vanekova L; Smola M; Klíma M; Břehová P; Buděšínský M; Dračínský M; Procházková E; Zavřel M; Šimák O; Páv O; Boura E; Birkuš G; Nencka R
Structure; 2022 Aug; 30(8):1146-1156.e11. PubMed ID: 35690061
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure and functional implication of bacterial STING.
Ko TP; Wang YC; Yang CS; Hou MH; Chen CJ; Chiu YF; Chen Y
Nat Commun; 2022 Jan; 13(1):26. PubMed ID: 35013136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
